Hypophosphataemia in patients undergoing bone marrow transplantation.
We studied the prevalence of hypophosphataemia (< 0.80 mmol/l) in seventeen patients who had undergone bone marrow transplantation (BMT). Thirteen (77%) of the seventeen patients had hypophosphataemia at some stage during the conditioning phase or after their BMT. Seven (41%) of the seventeen patients had hypophosphataemia in the peri-BMT period that is during the conditioning phase or within one week thereafter. Two of the patients showed severe hypophosphataemia (< 0.30 mmol/l). We suggest that plasma phosphate should be monitored in patients with a bone marrow transplant.
Crook
M
M
Department of Chemical Pathology, UMDS, Guy's Hospital, London, UK.
Swaminathan
R
R
Schey
S
S
D000328:Adult; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017674:Hypophosphatemia / Q000097:blood / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood
D010710:Phosphates